Related Experiment Videos
Epstein-Barr virus associated lymphoproliferations in the AIDS setting
1Division of Hematologic Malignancies, Department of Oncology, and Viral Oncology Program, Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1650 Orleans Street, Baltimore, MD 21231, USA. rambind@jhmi.edu
European Journal of Cancer (Oxford, England : 1990)
|June 26, 2001
Summary
Epstein-Barr virus (EBV) drives B cell proliferation and can cause lymphomas, particularly in HIV patients. Understanding EBV
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Epstein-Barr virus (EBV), a gammaherpesvirus, infects B lymphocytes, leading to initial proliferation and later establishment of a viral reservoir.
- EBV is linked to various malignancies, including posttransplant lymphoproliferative disease, Burkitt's lymphoma (BL), and Hodgkin's disease (HD).
- While EBV is found in a minority of BL cases, it is nearly always associated with HD in HIV-infected individuals.
Purpose of the Study:
- To elucidate the pathogenesis of EBV-associated lymphomas.
- To explore the diagnostic and therapeutic strategies for EBV-related cancers, especially in the context of HIV infection.
Main Methods:
- Review of EBV's role in B cell infection and latency.
- Analysis of EBV association with specific lymphomas like BL and HD.
- Evaluation of EBV-directed T cell therapies in posttransplant settings.
Main Results:
- EBV infection involves distinct phases of viral gene expression and B cell proliferation.
- HIV-associated lymphomas, including primary CNS and immunoblastic lymphomas, share similarities with posttransplant lymphoproliferative disease.
- EBV detection in cerebrospinal fluid aids in diagnosing primary CNS lymphoma.
Conclusions:
- A comprehensive understanding of EBV's role in tumorigenesis is crucial for developing novel diagnostic and therapeutic approaches.
- EBV-directed T cell therapies show promise for treating EBV-associated lymphomas in immunocompromised patients.